XPO1-Mediated EIF1AX Cytoplasmic Relocation Promotes Tumor Migration and Invasion in Endometrial Carcinoma

Table 2

The EIF1AX expression in endometrial carcinoma, precursor lesions, and normal endometrium.

Groups		Cytoplasmic EIF1AX expression						Nuclear EIF1AX expression
		—	+	++	+++	++++	PR (%)	—	+	++	+++	++++	PR (%)
NE	50	48	0	0	2	0	4.0	2	0	0	2	46	96.0
SEH	50	49	0	0	1	0	2.0	1	0	0	4	45	98.0
CEH	50	40	0	1	9	0	20.0	5	0	0	3	42	90.0
AEH	50	18	5	7	20	0	64.0	8	2	38	2	0	84.0
EEC	286	50	50	100	59	27	82.5^a,b,c,d	249	21	10	3	3	12.9^a,b,c,d
EC	315	56	52	104	65	38	82.2^a	272	22	12	5	4	13.7^a

^a, compared with normal endometrium; ^b, compared with SEH; ^c, compared with CEH; ^d, compared with AEH; NE: normal endometrium; SEH: simple endometrial hyperplasia; CEH: complex endometrial hyperplasia; AEH: endometrial atypical hyperplasia; PR: positive rate.